论文部分内容阅读
目的观察米非司酮辅助依沙吖啶羊膜腔内注射在二次疤痕子宫引产的应用效果。方法选取2010年11月-2013年11月收治的二次疤痕子宫引产孕妇86例,随机分为观察组与对照组各43例。对照组孕妇采用依沙吖啶羊膜腔内注射引产,观察组在对照组基础上采用米非司酮150mg顿服,观察2组孕妇的应用效果。结果2组引产成功率比较差异无统计学意义(P>0.05),但观察组孕妇的产后出血量、引产并发症、产程各项指标均优于对照组,差异有统计学意义(P<0.05)。结论米非司酮辅助依沙吖啶羊膜腔内注射用于二次疤痕子宫引产,安全有效,并发症少,值得临床推广。
Objective To observe the effect of mifepristone adjunctive enamethasone amniotic fluid injection in secondary scar induced uterine abortion. Methods Eighty-six pregnant women with second-degree scar induced by induction of abortion were selected from November 2010 to November 2013 and were randomly divided into observation group and control group with 43 cases each. Pregnant women in the control group were treated with amniotic fluid injection of amniotic fluid. The observation group was treated with mifepristone 150 mg on the basis of the control group, and the effect of the two groups of pregnant women was observed. Results There was no significant difference in the success rate of induction of labor between the two groups (P> 0.05). However, the postpartum hemorrhage, induction of labor complications and the indexes of labor process in the observation group were all better than those in the control group (P <0.05 ). Conclusions Mifepristone is an effective adjunctive to ertaccharidum for secondary scar induced uterine abortion, which is safe and effective with few complications. It is worthy of clinical promotion.